A large-scale, multi-center clinical trial is under way in the US and Canada to determine whether a vitamin-like substance called coenzyme Q10, in high doses, can slow the progression of Parkinson’s disease.
A large-scale, multi-center clinical trial is under way in the US and Canada to determine whether a vitamin-like substance called coenzyme Q10, in high doses, can slow the progression of Parkinson’s disease.